OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Expression of Egfl7 in Human Normal Tissues and Epithelial Tumors
Chun Fan, Lian‐Yue Yang, Fan Wu, et al.
The International Journal of Biological Markers (2013) Vol. 28, Iss. 1, pp. 71-83
Open Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells
Yunliang Wang, Fenglin Dong, Jian Yang, et al.
Asian Pacific Journal of Cancer Prevention (2015) Vol. 16, Iss. 9, pp. 4065-4069
Open Access | Times Cited: 11

The Polymorphism and Expression of EGFL7 and miR-126 Are Associated With NSCLC Susceptibility
Weipeng Liu, Yunyun Zhang, Fengdan Huang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7

Increased expression of epidermal growth factor-like domain-containing protein 7 is predictive of poor prognosis in patients with hepatocellular carcinoma
Chao Yang, Yunliang Wang, Ding Sun, et al.
Journal of Cancer Research and Therapeutics (2018) Vol. 14, Iss. 4, pp. 867-872
Open Access | Times Cited: 10

Expression of epidermal growth factor-like domain 7 may be a predictive marker of the effect of neoadjuvant chemotherapy for locally advanced uterine cervical cancer
Makoto Yamauchi, Takeshi Fukuda, Takuma Wada, et al.
Oncology Letters (2016) Vol. 12, Iss. 6, pp. 5183-5189
Open Access | Times Cited: 9

Role of EGFL7 in human cancers: A review
Cristiane de Oliveira, Paola Gyuliane Gonçalves, Lucas Tadeu Bidinotto
Journal of Cellular Physiology (2023) Vol. 238, Iss. 8, pp. 1756-1767
Open Access | Times Cited: 3

High EGFL7 expression may predict poor prognosis in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
Zhiheng Cheng, Yifeng Dai, Yifan Pang, et al.
Cancer Biology & Therapy (2019) Vol. 20, Iss. 10, pp. 1314-1318
Open Access | Times Cited: 8

Multivariate analysis of molecular markers in peripheral blood associated with recurrence and metastasis of hepatocellular carcinoma
Xiaojing Liu, B. Wang, Weiwei Jiang, et al.
Genetics and Molecular Research (2015) Vol. 14, Iss. 1, pp. 1502-1507
Open Access | Times Cited: 7

Epidermal growth factor-like domain multiple 7 (EGFL7): Expression and possible effect on biliary epithelium growth in cholangiocarcinoma
Caterina Loredana Mammola, Antonella Vetuschi, Luigi Pannarale, et al.
European Journal of Histochemistry (2018) Vol. 62, Iss. 4
Open Access | Times Cited: 7

Expression of Epidermal Growth Factor-like Domain 7 is Increased by Transcatheter Arterial Embolization of Liver Tumors
Zhi Li, Caifang Ni, Jin Zhou, et al.
Asian Pacific Journal of Cancer Prevention (2015) Vol. 16, Iss. 3, pp. 1191-1196
Open Access | Times Cited: 6

EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome
Bruno Henrique Bressan da Costa, Aline Paixão Becker, Luciano Neder, et al.
Journal of Pathology and Translational Medicine (2022) Vol. 56, Iss. 4, pp. 205-211
Open Access | Times Cited: 4

Nanomedicine for the Treatment of Advanced Prostate Cancer
Sonia Vicente‐Ruiz, Antoni Serrano‐Martí, Ana Armiñán, et al.
Advanced Therapeutics (2020) Vol. 4, Iss. 1
Closed Access | Times Cited: 5

Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma
Mengyuan Yang, Fan Wu, Feng Fang, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 5

A Pan-Cancer Study of Epidermal Growth Factor-Like Domains 6/7/8 as Therapeutic Targets in Cancer
Shanping Shi, Ting Ma, Xi Yang
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 5

EGFL7: An emerging biomarker with great therapeutic potential
Carina Fabian, Sukrit Mahajan, Mirko H. H. Schmidt
Pharmacology & Therapeutics (2024), pp. 108764-108764
Closed Access

Low EGFL7 expression is associated with high lymph node spread and invasion of lymphatic vessels in colorectal cancer
Cristiane de Oliveira, Sandra F. Martins, Paola Gyuliane Gonçalves, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Impact of Activation of EGFL7 within Microenvironment of High Grade Ovarian Serous Carcinoma on Infiltration of CD4+ and CD8+ Lymphocytes
Jacek Jan Sznurkowski, Anton Żawrocki, Natalia Krawczyńska, et al.
Medicina (2022) Vol. 58, Iss. 5, pp. 588-588
Open Access | Times Cited: 1

Epidermal growth factor-like domain-containing protein 7 (Egfl7) as a new potential target for therapy in gynecologic oncology
Karolina Król, Jacek Jan Sznurkowski
Ginekologia Onkologiczna/Current Gynecologic Oncology (2016) Vol. 14, Iss. 3, pp. 162-167
Open Access

Prostate cancer: Delivery aspect and prospect
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal, et al.
Elsevier eBooks (2020), pp. 515-545
Closed Access

Activation of EGFL7 within High Grade Ovarian Serous Carcinoma is Associated with Lower Tumor Infiltrating CD4+ and CD8+ Lymphocytes
Jacek Jan Sznurkowski, Anton Żawrocki, Natalia Krawczyńska, et al.
Research Square (Research Square) (2020)
Closed Access

Previous Page - Page 2

Scroll to top